ArticleHaematologica2019

Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation.

Károly Jambrovics et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.